Kura Oncology Company Profile (NASDAQ:KURO)

About Kura Oncology (NASDAQ:KURO)

Kura Oncology logo

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: NASDAQ:KURO
  • CUSIP: N/A
  • Web: N/A
Capitalization:
  • Market Cap: $174.1 million
  • Outstanding Shares: 14,508,000
Average Prices:
  • 50 Day Moving Avg: $12.00
  • 200 Day Moving Avg: $12.00
  • 52 Week Range: $12.00 - $12.00
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -4.80
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: N/A
  • Price / Sales: N/A
  • Book Value: $4.08 per share
  • Price / Book: 2.94
Profitability:
  • EBITDA: ($11,800,000.00)
 

Frequently Asked Questions for Kura Oncology (NASDAQ:KURO)

What is Kura Oncology's stock symbol?

Kura Oncology trades on the NASDAQ under the ticker symbol "KURO."

Who are some of Kura Oncology's key competitors?

Who owns Kura Oncology stock?

Kura Oncology's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include ECOR1 CAPITAL, LLC Total Shares: 3,766,852 (13.60%) and GREAT POINT PARTNERS LLC (5.92%). View Institutional Ownership Trends for Kura Oncology.

How do I buy Kura Oncology stock?

Shares of Kura Oncology can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Kura Oncology's stock price today?

One share of Kura Oncology stock can currently be purchased for approximately $12.00.


MarketBeat Community Rating for Kura Oncology (NASDAQ KURO)
Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  33 (Vote Outperform)
Underperform Votes:  26 (Vote Underperform)
Total Votes:  59
MarketBeat's community ratings are surveys of what our community members think about Kura Oncology and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Kura Oncology (NASDAQ:KURO) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A
Consensus Price Target History for Kura Oncology (NASDAQ:KURO)
Price Target History for Kura Oncology (NASDAQ:KURO)
Analysts' Ratings History for Kura Oncology (NASDAQ:KURO)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
12/30/2015Oppenheimer Holdings, Inc.Initiated CoverageOutperformN/AView Rating Details
(Data available from 10/22/2015 forward)

Earnings

Earnings History for Kura Oncology (NASDAQ:KURO)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Kura Oncology (NASDAQ:KURO)
Current Year EPS Consensus Estimate: $-2.58 EPS
Next Year EPS Consensus Estimate: $-2.50 EPS

Dividends

Dividend History for Kura Oncology (NASDAQ:KURO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Kura Oncology (NASDAQ:KURO)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Kura Oncology (NASDAQ:KURO)
Latest Headlines for Kura Oncology (NASDAQ:KURO)
Source:
Loading headlines, please wait.

Social

Chart

Kura Oncology (KURO) Chart for Sunday, October, 22, 2017

This page was last updated on 10/22/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.